Med-tech deal value, excluding M&As, totaled $628.41 million in the first quarter (Q1) of 2026, an increase of about 322% from the $149.08 million recorded in Q1 2025 though a 36% drop from Q4 2025‘s $978.58 million.

Med-tech M&A activity totaled $18.2 billion in January and February 2026, marking one of the stronger openings in recent years.